Background Hepatic artery thrombosis (HAT) represents a devastating and often fatal
complication of liver transplantation. Due to the small vessel caliber in pediatric patients, the …

Objective To conduct a randomized double‐blind prospective study to investigate effect of
different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST …

Introduction In pediatric liver transplantation (pLT), hepatic artery thrombosis (HAT) is
associated with inferior transplant outcome. Hepatic artery reconstruction (HAR) using an …

Background Systemic anticoagulation after pediatric liver transplantation (pLT) is believed to
reduce the incidence of vascular thrombosis, but it may also cause an increase in …

Background Pediatric LT are at particular risk of HAT, and its management still constitutes a
matter of debate. Our purpose was to study predisposing factors and outcome of HAT post …

Background/purpose The incidence of hepatic artery thrombosis (HAT) in recipients is high
after pediatric LT using young donors. In this study we investigated the management and …

Background Pro-and anticoagulant drugs are commonly used in pediatric liver
transplantation to prevent and treat thrombotic and bleeding complications. However, the …

Chronic liver disease (CLD) is prone to both thrombosis and bleeding because of altered
hemostasis marked by impaired regulation of platelet function/aggregation, and a decrease …

Recipient outcomes after pediatric liver transplantation improved significantly over the years.
Two of the main challenges remain thrombotic and bleeding complications, which both …

Background: Pro-and anticoagulant drugs are commonly used in pediatric liver
transplantation to prevent and treat thrombotic and bleeding complications. However, the …